Oric Pharmaceuticals (ORIC) Earnings Date, Estimates & Call Transcripts $10.74 +0.09 (+0.85%) As of 10:59 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Oric Pharmaceuticals Earnings Summary Oric Pharmaceuticals announced Q1 2025 earnings on May 5, 2025, reporting an EPS of -$0.42, which topped the consensus estimate of -$0.51 by $0.09. With a trailing EPS of -$1.87, Oric Pharmaceuticals' earnings are expected to grow next year, from ($2.17) to ($1.96) per share. Upcoming Q2 Earnings DateAug. 11Before Market OpensEstimatedConsensus EPS (May. 5) -$0.51 Actual EPS (May. 5) -$0.42 Beat By $0.09 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)ORIC Upcoming EarningsOric Pharmaceuticals' next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules. Powered by Get Oric Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oric Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataORIC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Oric Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.53-$0.50-$0.52Q2 20252-$0.55-$0.48-$0.52Q3 20252-$0.57-$0.47-$0.52Q4 20252-$0.58-$0.47-$0.53 Oric Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/11/2025(Estimated)--------5/5/2025Q1 2025-$0.51-$0.42+$0.09-$0.42--2/18/2025Q4 2024-$0.52-$0.51+$0.01-$0.51--11/12/2024--$0.48-$0.49 -$0.01-$0.49--8/12/2024Q2 2024-$0.42-$0.45 -$0.03-$0.45--5/6/2024Q1 2024-$0.44-$0.37+$0.07-$0.37--3/11/2024--$0.49-$0.49--$0.49--11/6/2023Q3 2023-$0.46-$0.44+$0.02-$0.44--8/10/2023Q2 2023-$0.58-$0.50+$0.08-$0.50-- Oric Pharmaceuticals Earnings - Frequently Asked Questions When is Oric Pharmaceuticals' earnings date? Oric Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on ORIC's earnings history. Did Oric Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Oric Pharmaceuticals (NASDAQ:ORIC) reported ($0.42) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.51) by $0.09. Learn more on analysts' earnings estimate vs. ORIC's actual earnings. How much profit does Oric Pharmaceuticals generate each year? Oric Pharmaceuticals (NASDAQ:ORIC) has a recorded net income of -$127.85 million. ORIC has generated -$1.87 earnings per share over the last four quarters. What is Oric Pharmaceuticals' EPS forecast for next year? Oric Pharmaceuticals' earnings are expected to grow from ($2.17) per share to ($1.96) per share in the next year. More Earnings Resources from MarketBeat Related Companies RNA Earnings Date RARE Earnings Date PTGX Earnings Date SRRK Earnings Date MLTX Earnings Date MTSR Earnings Date VKTX Earnings Date KYMR Earnings Date CRNX Earnings Date ALVO Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:ORIC) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredA “starter home” for $1925?An MIT startup just slashed the cost of producing the world’s most valuable metal — by 99%. This “miracle m...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oric Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oric Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.